Poster (Scientific congresses and symposiums)
Theurapeutic approach combining PD-1/PD-L1 blockade and the inhibition of "new" immune checkpoints for the treatment of triple-negative breast cancer
Ancion, Marie
2021European Association for Cancer Research Congress 2021
 

Files


Full Text
EACR21v-0238-PosterMarieAncion.pdf
Publisher postprint (2.59 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Immunotherapy; Triple-negative breast cancer
Research center :
Laboratoire de Pathologie Expérimentale, GIGA-Cancer
Disciplines :
Oncology
Author, co-author :
Ancion, Marie ;  Université de Liège - ULiège > GIGA Cancer - Experimental Pathology
Language :
English
Title :
Theurapeutic approach combining PD-1/PD-L1 blockade and the inhibition of "new" immune checkpoints for the treatment of triple-negative breast cancer
Publication date :
09 June 2021
Number of pages :
e-Poster
Event name :
European Association for Cancer Research Congress 2021
Event organizer :
EACR
Event date :
Du 9 juin au 12 juin 2021
Audience :
International
Name of the research project :
Therapeutic approach combining PD-1/PD-L1 blockade and the inhibition of “new” immune checkpoints for the treatment of triple-negative breast cancer
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
Available on ORBi :
since 23 September 2021

Statistics


Number of views
52 (11 by ULiège)
Number of downloads
2 (2 by ULiège)

Bibliography


Similar publications



Contact ORBi